Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Jerry Isaacson joins Roth as managing director and senior research analyst

Jerry Isaacson has joined Roth Capital Partners as a managing director and senior research analyst covering biotechnology and emerging therapeutics.

November 5, 2018

Executive Moves

Breath Therapeutics names Peter Shadday as chief commercial officer

Closely-held Breath Therapeutics appointed Peter Shadday as chief commercial officer to lead the company’s market access activities and product commercialization.

October 17, 2018

Executive Moves

ContraVir Pharma names biotech industry veteran, Robert Foster, as acting CEO

ContraVir Pharmaceuticals (NASDAQ:CTRV) appointed industry veteran, Robert Foster, as acting CEO, succeeding James Sapirstein.

October 3, 2018

Executive Moves

Imagin Medical names Chris Bleck to its board

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart:DPD2) named Chris Bleck to its board.

October 2, 2018

Executive Moves

Titan Pharma hires commercialization veteran, Dane Hallberg

Titan Pharmaceuticals (NASDAQ:TTNP) appointed Dane Hallberg to the newly created position of EVP and chief commercial officer, effective immediately, with responsibility for leading all of the company’s commercial...

October 2, 2018

Executive Moves

Ondine Biomedical names Cameron Lawrence as COO, CFO

Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.

October 1, 2018

Executive Moves

Raymond James names Dane Leone as a managing director in biotech research

Raymond James appointed Dane Leone as a managing director responsible for biotechnology coverage in the firm’s equity research department.

October 1, 2018

Executive Moves

3DS names Sherif Louis as CEO

3D Signatures (TSX:DXD) appointed Sherif Louis, as the company's chief executive officer.

September 25, 2018

Executive Moves

Vincent Gardès joins Truffle Capital’s biomed team as senior partner

Truffle Capital appointed Vincent Gardès to its biomed team as a senior partner, joining Dr. Philippe Pouletty, Alain Chevallier and Antoine Pau.

September 20, 2018

Executive Moves

Shawn Cross joins JMP healthcare investment banking division

JMP Group (NYSE:JMP) named Shawn Cross as a managing director in its healthcare investment-banking group with a focus on the biotechnology and biopharmaceutical sectors.

September 20, 2018

Executive Moves

mdBriefCase names Jason Flowerday as CEO

mdBriefCase, a leading provider of online continuing professional development for physicians, pharmacists, nurses, and other allied healthcare professionals, appointed Jason Flowerday as CEO.

September 17, 2018

Executive Moves

BioSyent names new CFO; adds VP corporate development

BioSyent (TSXV:RX) appointed Robert March as VP of finance and CFO, succeeding Alfred D’Souza, who has retired after 12 years of service to the company, but will ensure a smooth transition to Mr. March and continue to...

September 11, 2018

Executive Moves

Soricimed names Vaughn Embro-Pantalony as chairman, Susan Hicks to BOD

Closely-held Soricimed Biopharma named Vaughn Embro-Pantalony, a current director, as chairman and Susan Hicks to its board, both effective immediately. Mr. Embro-Pantalony, who joined Soricimed’s board in March 2018...

September 4, 2018

Executive Moves

Scott Smith joins board of Spring Bank Pharma

Spring Bank Pharmaceuticals (NASDAQ:SBPH) named Scott Smith as an independent member of the board, replacing Jonathan Bates, who is stepping down as a director after 10 years of service with the company.

August 17, 2018

Executive Moves

James Molloy joins equity research team at A.G.P./Alliance

James Molloy has joined A.G.P./Alliance Global Partners as a managing director and biotechnology and specialty pharmaceuticals equity research analyst. He will provide coverage of companies in several therapeutic...

August 14, 2018

Executive Moves

Carin Fradin joins JMP as a managing director investment banking

Carin Fradin has joined JMP Group (NYSE:JMP) as a managing director in its investment banking division.

June 19, 2018

Executive Moves

Rigel Pharma names Dean Schorno as EVP and CFO

Rigel Pharmaceuticals (NASDAQ:RIGL) appointed Dean Schorno as EVP and CFO.

May 30, 2018

Executive Moves

Dr. Mani Foroohar joins Leerink research team covering therapeutics

Dr. Mani Foroohar has joined Leerink Partners’ research team as a managing director and senior research analyst covering therapeutics stocks.

May 21, 2018

Executive Moves

Complexa names Francisco Salva as CEO, president

Closely-held Complexa appointed Francisco Salva as the company’s new CEO and president, effective immediately.

May 14, 2018

Executive Moves

Titan Pharma names Federico Seghi Recli as a director

Titan Pharmaceuticals (NASDAQ:TTNP) announced the appointment of Federico Seghi Recli to its board. An executive with over 24 years of leadership experience within the pharmaceutical industry, Mr. Seghi Recli has served...

May 14, 2018

Executive Moves

Aaron Davidson named CFO and SVP corporate development of Profound Medical

Profound Medical (TSXV:PRN; OTCQX:PRFMF) strengthened its management team, naming Aaron Davidson as CFO and SVP of corporate development, effective May 3, 2018. In a statement, Arun Menawat, CEO, said Mr. Davidson’s...

May 1, 2018

Executive Moves

Maxim Group expands biotech equity research team

Maxim Group expanded its equity research platform with the appointment of Caroline Palomeque as a SVP and a senior biotechnology analyst.

April 30, 2018

Subscribe